Linde stock trades near record territory as earnings and hydrogen investments underpin valuation

Linde stock is trading close to its record high as investors weigh resilient earnings growth, strong margins, and multiyear hydrogen and clean-energy investments alongside a premium valuation for the industrial-gas leader.

Linde plc (ISIN IE000S9YS4E6) stock is trading close to its record region after the industrial-gas group delivered higher adjusted earnings and robust free cash flow in 2024 while continuing to commit billions of dollars to long-term hydrogen and clean-energy projects, according to recent company disclosures and market data from the New York Stock Exchange.

Revenue above 2023 while margins stay high

According to Linde's latest full-year results for 2024 reported on its investor portal Linde, the company generated annual sales in the tens of billions of US dollars, reflecting an increase versus 2023 driven by pricing and ongoing project start-ups in its core industrial-gas and engineering activities. The report highlights that the company achieved higher operating profit compared with the prior year as cost discipline and portfolio management offset headwinds from energy prices in several regions.

In the same 2024 report, Linde stated that it maintained an attractive operating margin at a level comfortably above many traditional heavy-industry peers, with the margin fractionally higher than in 2023 as mix shifted toward on-site and merchant business with pricing power. This margin performance supported an increase in adjusted earnings per share versus the previous year, underscoring the cash-generative nature of long-term take-or-pay supply contracts in sectors such as chemicals, refining, metals, electronics, and healthcare.

Capital spending and hydrogen pipeline reach billions

Linde's 2024 capital expenditure program, as outlined in its annual disclosures on Linde, ran into multiple billions of US dollars, including a large slate of new on-site gas plants and clean-energy projects. Over a multiyear horizon, the company has described a project backlog also measured in the tens of billions of dollars, illustrating the scale of customer commitments in areas such as low-carbon hydrogen, ammonia, and carbon capture for industrial clients.

Within this total, Linde has earmarked several billions of dollars specifically for hydrogen-related investments, including both traditional industrial hydrogen supply and lower-carbon solutions using technologies such as electrolysis and autothermal reforming paired with carbon capture. These project commitments extend over several years and are anchored by customer offtake contracts, which the company has stated are expected to support continued revenue and earnings growth into the medium term as projects enter service.

Healthcare gases and electronics support growth

Linde derives a significant portion of its revenue from supplying industrial and medical gases such as oxygen, nitrogen, argon, and specialty mixtures to hospitals, semiconductor manufacturers, and other high-specification customers, according to its segment breakdown on Linde. In its most recent annual review, the company showed that healthcare-related sales and electronics gases both grew versus the prior year, contributing to the overall revenue increase and supporting margins because these products often carry higher value-added services and stringent quality requirements.

The company reports that its backlog includes several new semiconductor projects and hospital contracts which are expected to incrementally add to revenue over the coming years once installations are completed and long-term supply contracts start. This pipeline suggests that the mix of business could lean further toward higher-margin end markets, providing an additional layer of support for profitability alongside efficiency programs already in place.

Technical gases remain core product line

Linde's portfolio of industrial and medical gases remains at the heart of its business model, with oxygen standing out as one of its most widely used products across sectors ranging from steelmaking to healthcare. According to the company information presented on Linde, gaseous and liquid oxygen is supplied either through on-site plants connected directly to customer facilities or via bulk and cylinder distribution networks that cover industrial clusters and hospitals in North America, Europe, Asia, and other regions.

Beyond oxygen, Linde also emphasizes products such as nitrogen, hydrogen, and specialty gases in applications including food processing, electronics manufacturing, and clean-energy projects. The company notes in its materials that the breadth of its product offering and global footprint enables it to serve multinational customers with consistent quality and safety standards, which can be a competitive advantage when bidding for multi-site or multiyear contracts in capital-intensive industries.

Share listing and market positioning

Linde stock is primarily listed on the New York Stock Exchange under the ticker symbol LIN, reflecting its position as a large-cap industrial-gas company included in major indices such as the S&P 500 and other widely followed benchmarks. Market data providers show that the company is among the most valuable industrial names globally by market capitalization, reflecting investor expectations for stable cash flows and growth from energy-transition investments.

Analysts and investors often compare Linde with global peers in the industrial-gas sector when assessing valuation, taking into account its margin profile, capital spending intensity, and exposure to growth themes such as low-carbon hydrogen, clean fuels, and advanced manufacturing. The combination of a sizable project backlog, disciplined capital allocation, and consistent free cash flow generation forms an important part of the investment narrative used to justify its current valuation range.

Key data on Linde

• Company: Linde plc
• ISIN: IE000S9YS4E6
• Ticker: NYSE: LIN
• Trading venue: New York Stock Exchange
• Sector / Industry: Materials / Industrial Gases
• Index membership: S&P 500